Management of Mural Thrombus Outside the Endograft After EVAR
A mural thrombus located outside the endograft after EVAR requires close surveillance with imaging at 6-12 months, and if the aneurysm sac is growing ≥10 mm, embolization should be considered; if growth is <10 mm or the sac is shrinking, continue surveillance every 6 months for 24 months. 1
Surveillance Strategy
The management approach depends critically on whether the thrombus is causing aneurysm sac expansion:
Initial Assessment (6-12 Months Post-EVAR)
- Obtain contrast-enhanced CT (CCT) or duplex ultrasound/contrast-enhanced ultrasound (DUS/CEUS) to evaluate:
- Aneurysm sac diameter change
- Presence of endoleak
- Thrombus characteristics
If Sac Growth ≥10 mm:
- Consider embolization if technically feasible (Class IIa recommendation) 1
- This represents significant expansion that increases rupture risk and warrants intervention
- Embolization is preferred over open surgery as the first-line endovascular approach
If Sac Growth <10 mm or Shrinking:
- Continue surveillance imaging every 6 months for the first 24 months 1
- After 24 months, transition to annual surveillance for the first 5 years
- After 5 years without complications, imaging can be extended to every 5 years 2
Important Clinical Considerations
The key distinction is whether this represents an endoleak or simply residual mural thrombus in the excluded aneurysm sac. If there is active flow (endoleak) maintaining pressure in the sac, this requires more aggressive management than simple mural thrombus.
Risk Factors to Monitor:
- Anticoagulation therapy increases risk of persistent issues 1
- Type II endoleaks (from branch vessel backfilling) occur in ~25% of patients and may seal spontaneously in ~50% of cases 1
- Significant sac expansion (≥10 mm) is the critical threshold that triggers consideration for re-intervention 1
Imaging Modality Selection:
- CCT with contrast is the gold standard for thorough evaluation 1, 2
- DUS/CEUS is acceptable for routine surveillance if no concerning findings 2
- In renal failure, combine non-contrast CCT with DUS/CEUS 1
Common Pitfalls to Avoid
Don't ignore slow sac growth (<10 mm): While not requiring immediate intervention, this still mandates closer surveillance intervals (every 6 months rather than annually)
Don't assume all mural thrombus is benign: The thrombus itself may be a source of distal embolization, particularly if mobile 3, 4. If embolic complications occur, more aggressive intervention including endovascular coverage or open surgery may be necessary 3
Don't delay imaging: The 30-day post-EVAR imaging is mandatory (Class I recommendation) to establish baseline 1, 2
The evidence strongly supports a surveillance-first approach for mural thrombus outside the endograft, with intervention reserved for documented sac expansion ≥10 mm, which represents the threshold where rupture risk becomes unacceptable.